Previous Close | 8.63 |
Open | 8.61 |
Bid | 8.39 x 4000 |
Ask | 8.57 x 4000 |
Day's Range | 8.19 - 8.61 |
52 Week Range | 7.70 - 33.97 |
Volume | |
Avg. Volume | 2,765,861 |
Market Cap | 1.196B |
Beta (5Y Monthly) | 0.94 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.26 |
Earnings Date | Nov 01, 2022 - Nov 07, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 21.31 |
Subscribe to Yahoo Finance Plus to view Fair Value for AUPH
The Aurinia Pharmaceuticals Inc. ( NASDAQ:AUPH ) share price is down a rather concerning 32% in the last month. But...
Shares of commercial-stage autoimmune disease specialist Aurinia Pharmaceuticals (NASDAQ: AUPH) raced higher in early action Thursday morning, rising as much as 15.7%. Why did investors bid up Aurinia's shares?
Aurinia (AUPH) delivered earnings and revenue surprises of -13.64% and 4.14%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?